Study | Exclusion reasons | Rmk | Reference |
---|---|---|---|
Coste (Oxcarbazepine) (Controls unexposed, sick), 2020 | EXCLUDED: this control group doesn't exist in the article (only in the report). Children with a diagnosis of brain malformation (ICD-10 codes Q00 to Q04 and Q05.0 to Q05.4) during their stay in the maternity unit are excluded. | ||
He (Oxcarbazepine) (Controls unexposed, sick), 2017 | repeat population groups, duplicate reports (most recent study included) | Patients who developed epilepsy during pregnancy or after delivery were not included. Overlapping: He 2017 totally included in Li 2023, with a longer study period and more pregnancies => Use of Li 2023. |
He Epilepsy Behav 2017; 74:10-14 10.1016/j.yebeh.2017.05.034 |
He (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2017 | repeat population groups, duplicate reports (most recent study included) | Patients who developed epilepsy during pregnancy or after delivery were not included. Overlapping: He 2017 totally included in Li 2023, with a longer study period and more pregnancies => Use of Li 2023. |
He Epilepsy Behav 2017; 74:10-14 10.1016/j.yebeh.2017.05.034 |